UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 31, 2005

MICROVISION, INC.

(Exact Name of Registrant as Specified in Charter)

Registrant’s telephone number, including area code: (425) 415-6847

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Microvision, Inc. (the “Company”) entered into a Securities Purchase Agreement dated as of August 31, 2005 (the “Purchase Agreement”) with Omicron Master Trust (“Omicron”) providing for the sale of 285,714 shares of the Company’s Common Stock (the “Common Shares”) and a warrant to purchase a total of 64,373 shares of the Company’s common stock (the “Warrant”) for an aggregate purchase price of $1,500,000. The Company issued the Common Shares and the Warrant on August 31, 2005 (the “Closing Date”).

The Warrant expires on August 31, 2010. The initial exercise price of the Warrant is $6.50 per share and is subject to adjustment in the event of certain below market and dilutive issuances.

The Company also entered into a Registration Rights Agreement with respect to the issuance of the Common Shares and the Warrant. The Company has agreed to file a registration statement with respect to the Common Shares and the shares of the Company’s common stock issuable under the Warrant as soon as practicable and in any event within 30 days of the Closing Date, and to use its best efforts to cause the Registration Statement to become effective as soon as practicable thereafter, and in no event later than 120 days following the Closing Date.

The foregoing description is qualified in its entirety by the terms of the Purchase Agreement, the Registration Rights Agreement and the Warrant attached hereto as Exhibits 10.1, 10.2 and 4.1, respectively, which are each incorporated herein by reference.

The Company issued the Common Shares and the Warrant on August 31, 2005 in a transaction not involving any public offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The terms of the issuance are described in Item 1.01 of this Report and are incorporated herein by reference.

(c) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 1, 2005

EXHIBIT INDEX